News Medical on MSN2h
New drug approach shows promise in treating metabolic liver diseases
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
MedPage Today on MSN5d
FDA Issues Safety Alert on Liver Disease Drug
Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis ...
Liver Disease Is Often Silent—Here Are the Subtle Signs to Look Out For
Since liver disease has no noticeable symptoms in the early stages, the best thing you can do is proactively get tested. “It ...
Scientists Have Identified Two Distinct Types of Fatty Liver Disease
Two types of fatty liver disease discovered, enhancing diagnosis and treatment. Researchers at Karolinska Institutet and the ...
A blood test may be a more reliable indicator of liver disease than asking how much a person drinks
A new study finds that a blood test may be a more reliable indicator of liver disease than asking how much a person drinks.
Verywell Health on MSN1d
How Liver Elastography Test Works
Liver elastography confirms liver fibrosis (stiffness) and helps providers reach a diagnosis to suggest treatment. Learn ...
Teen sues food giants over ultra-processed foods after being diagnosed with fatty liver disease
Fox News senior medical analyst Dr. Marc Siegel weighs in on the harmful impact of ultra-processed foods as a U.S. teen ...
Science Daily1d
Liver Disease News
Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces liver fat ... Liver Transplant Outperforms Other Therapies for ...
FDA Approves First Fatty Liver Disease Drug: Who It’s For and How It Works
For those dealing with fatty liver disease, there’s welcome news to report. Earlier this year, the United States Food and ...
Hosted on MSN1d
GILD Obtains Positive CHMP Opinion for Liver Disease Drug
Gilead Sciences, Inc. GILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European ...
The Lancet1d
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects around 30% of the global population. Studies suggest ...
UPI13d
Poor sleep might be hallmark of obesity-linked liver disease
Fatty liver disease may contribute to fragmented sleep patterns, robbing already sick people of good rest, a new study finds.